Bank of Montreal
XLRN

Bank of Montreal’s Acceleron Pharma XLRN Stock Holding History

Bank of Montreal’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$390K – 4266
2014
Q4 		$390K Buy
+10,000
New +$349K ﹤0.01% 2190

Bank of Montreal's XLRN Position: Q4 2021 in Review

Bank of Montreal sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 54,069 shares — an estimated $9.55M sold.

Bank of Montreal first reported a position in XLRN in Q2 2014 and held it in 21 quarters. The position peaked at $25.1M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Bank of Montreal reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 54,069 Acceleron Pharma shares in Q4 2021, an estimated $9.55M.
  • Bank of Montreal first reported a position in Acceleron Pharma in Q2 2014 and held it in 21 quarters.
  • Bank of Montreal's Acceleron Pharma position peaked at $25.1M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.